Westbourne Investments’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
6,744
-500
-7% -$138K 0.61% 48
2026
Q1
$2.14M Buy
7,244
+1,000
+16% +$297K 1.02% 32
2025
Q4
$1.71M Sell
6,244
-145
-2% -$39.4K 0.79% 39
2025
Q3
$1.7M Sell
6,389
-995
-13% -$271K 0.81% 42
2025
Q2
$2.04M Buy
7,384
+4,734
+179% +$1.29M 1.09% 26
2025
Q1
$703K Buy
+2,650
New +$654K 0.42% 63

Other funds holding CME

Westbourne Investments's CME Position: Q2 2026 in Review

Westbourne Investments reduced its CME Group (CME) stake by 6.9% in Q2 2026, selling an estimated $138K and leaving 6,744 shares worth $1.49M. The position accounts for 0.61% of the portfolio, ranked #48.

Westbourne Investments first reported a position in CME in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.14M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Westbourne Investments held 6,744 shares of CME Group worth $1.49M as of Q2 2026.
  • Westbourne Investments sold 500 CME Group shares in Q2 2026, an estimated $138K.
  • CME Group made up 0.61% of Westbourne Investments's portfolio in Q2 2026, its #48 holding.
  • Westbourne Investments first reported a position in CME Group in Q1 2025 and has held it in 6 quarters since.
  • Westbourne Investments's CME Group position peaked at $2.14M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Westbourne Investments's 13F filing for Q2 2026, filed 11 Aug 2026.